Asia Pacific Artificial Intelligence In Cancer Diagnostics Market Size & Outlook
Asia Pacific artificial intelligence in cancer diagnostics market, 2018-2030 (US$M)
Related Markets
Asia Pacific artificial intelligence in cancer diagnostics market highlights
- The Asia Pacific artificial intelligence in cancer diagnostics market generated a revenue of USD 41.7 million in 2023.
- The market is expected to grow at a CAGR of 28.9% from 2024 to 2030.
- In terms of segment, software was the largest revenue generating component type in 2023.
- Services is the most lucrative component type segment registering the fastest growth during the forecast period.
- Country-wise, Australia is expected to register the highest CAGR from 2024 to 2030.
Asia Pacific data book summary
| Market revenue in 2023 | USD 41.7 million |
| Market revenue in 2030 | USD 247.4 million |
| Growth rate | 28.9% (CAGR from 2023 to 2030) |
| Largest segment | Software |
| Fastest growing segment | Services |
| Historical data covered | 2018 - 2022 |
| Base year for estimation | 2023 |
| Forecast period covered | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Software, Hardware, Services |
| Key market players worldwide | Microsoft Corp, Roche Holding AG, Quest Diagnostics Inc, Medial EarlySign, CancerCenter.AI, Therapixel, Tempus, Kheiron, SkinVision |
Other key industry trends
- In terms of revenue, Asia Pacific region accounted for 21.5% of the global artificial intelligence in cancer diagnostics market in 2023.
- Globally, North America is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 247.4 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Artificial Intelligence In Cancer Diagnostics Market Scope
Artificial Intelligence In Cancer Diagnostics Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Asia Pacific artificial intelligence in cancer diagnostics market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial intelligence in cancer diagnostics market will help companies and investors design strategic landscapes.
Software was the largest segment with a revenue share of 48.44% in 2023. Horizon Databook has segmented the Asia Pacific artificial intelligence in cancer diagnostics market based on software, hardware, services covering the revenue growth of each sub-segment from 2018 to 2030.
Increasing patient pool, growing acceptance of cloud computing, and rising number of government programs supporting AI are among the factors primarily driving the market growth. In addition, growing number of biopharmaceutical firms are applying AI to modernize the drug discovery process and expand AI applications in the field of diagnostics.
For instance, in 2017, China’s Tencent introduced an AI-driven diagnostic medical imaging facility called AI Medical Innovation System (AIMIS). The technology has exhibited 90% and 95% accuracy for initial diagnoses of esophageal and lung cancers, respectively.
Reasons to subscribe to Asia Pacific artificial intelligence in cancer diagnostics market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Asia Pacific artificial intelligence in cancer diagnostics market databook
-
Our clientele includes a mix of artificial intelligence in cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific artificial intelligence in cancer diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific artificial intelligence in cancer diagnostics market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Asia Pacific artificial intelligence in cancer diagnostics market size, by country, 2018-2030 (US$M)
Asia Pacific Artificial Intelligence In Cancer Diagnostics Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
